 The researchers found that a certain protein called C20Orph 116 was present in urine samples taken from patients with acute kidney injury, A.K.I. The higher the concentration of this protein, the greater the risk of developing A.K.I. This protein can be detected up to 24 hours before the patient's serum creatinine levels begin to increase, indicating that it may be useful as a predictive biomarker for A.K.I. This article was authored by Deshirina Zairi, Sarah Pagenda, Rebecca Ammuch, and others.